Share on StockTwits
 

USANA Health Sciences (NASDAQ:USNA) will post its Q413 quarterly earnings results on Wednesday, February 5th. Analysts expect USANA Health Sciences to post earnings of $1.22 per share and revenue of $175.53 million for the quarter. Individual interested in listening to the company’s earnings conference call can do so using this link.

USANA Health Sciences (NASDAQ:USNA) opened at 57.62 on Tuesday. USANA Health Sciences has a 52 week low of $35.70 and a 52 week high of $92.00. The stock’s 50-day moving average is $69.18 and its 200-day moving average is $76.48. The company has a market cap of $799.3 million and a price-to-earnings ratio of 11.04.

On a related note, analysts at Sidoti upgraded shares of USANA Health Sciences from a “neutral” rating to a “buy” rating in a research note to investors on Friday, November 8th. Four equities research analysts have rated the stock with a hold rating and one has given a buy rating to the company’s stock. The stock presently has a consensus rating of “Hold” and a consensus price target of $75.08.

USANA Health Sciences, Inc develops and manufactures science-based nutritional and personal care products.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.